GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mertk kinase domain in complex with gilteritinib

Analyse Crystal structure of mertk kinase domain in complex with gilteritinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7AB1
Type
protein
Length
270 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase mer
EC
2.7.10.1
UniProt
Q12866
Ligands
C6F, CL
Pockets
1 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase mer (EC 2.7.10.1)protein27044% helix, 17% strandQ12866

Ligands and binding sites

  • C6F · 6-ethyl-3-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl]phenyl]amino]-5-(oxan-4-ylamino) pyrazine-2-carboxamide · ligand · chains A
  • CL · Chloride ion · ion · 4 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12050.560.7935C6F

Compared structures

  • 7AB1 · Crystal structure of MerTK kinase domain in complex with Gilteritinib · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12866 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase mer (Q12866) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.